Corvus Pharmaceuticals (CRVS) Cash & Current Investments (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Cash & Current Investments of $215.23 million for Q2 2026, compared with $14.69 million a year earlier and down 9.1% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Cash & Current Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals posted Cash & Current Investments of $56.75 million, up 9.2% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $51.96 million in FY2024 (+311.8%), $12.62 million in FY2023 (-4.1%), $13.16 million in FY2022 (-79.3%) and $63.46 million in FY2021 (+285.6%).
- Five-year quarterly Cash & Current Investments spans a low of $2.87 million in Q3 2025 and a high of $236.71 million in Q1 2026.
- Year over year, Cash & Current Investments gained in two of the last six quarters, with growth averaging 28.6%.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2024 (growth of 311.8%); the low point was Q4 2022 (a decline of 79.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $236.71 million (Q1 2026), $56.75 million (Q4 2025) and $2.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | 215.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 215.23 Mn |
| Mar 31, 2026 | 236.71 Mn |
| Dec 31, 2025 | 56.75 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 14.69 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 51.96 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 14.84 Mn |
| Mar 31, 2024 | 7.46 Mn |
| Dec 31, 2023 | 12.62 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 24.59 Mn |
| Jun 30, 2022 | 28.48 Mn |
| Mar 31, 2022 | 31.46 Mn |
| Dec 31, 2021 | 63.46 Mn |
| Sep 30, 2021 | 72.30 Mn |
API Access
Corvus Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();